Summary
390.87 0.28(0.07%)07/16/2025
Stryker Corporation (SYK)
SYK reported last earnings on 2025-05-01 after the market. An EPS of $2.84 was observed compared to an estimated EPS of $2.71, resulting in a surprise value of $0.13. A revenue of $5,866 million was observed compared to an estimated revenue of $5,691 million, resulting in a surprise value of $175 Million.
Stryker Corporation (SYK)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 0.07 | -0.99 | 3.87 | 12.99 | 2.83 | 18.28 | 113.32 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B |
| Recommended Rating | Neutral |
| DCF | Buy |
| ROE | Neutral |
| ROA | Buy |
| Debt/Equity | Sell |
| P/E | Strong Sell |
| P/B | Neutral |
Earnings
| Trading Data | ||
| Close | 390.87 | |
| Open | 391.38 | |
| High | 391.42 | |
| Low | 385.93 | |
| Volume | 1,067,062 | |
| Change | 0.28 | |
| Change % | 0.07 | |
| Avg Volume (20 Days) | 1,300,005 | |
| Volume/Avg Volume (20 Days) Ratio | 0.82 | |
| 52 Week Range | 314.96 - 404.39 | |
| Price vs 52 Week High | -3.34% | |
| Price vs 52 Week Low | 24.10% | |
| Range | 0.00 | |
| Gap Up/Down | -1.39 | |
Profitibility | ||
| Market Capitalization (Mln) | 149,048 | |
| Revenue per share | 60.8279 | |
| Net Income per share | 7.4902 | |
| Dividend Yield | 0.0085 | |
| Dividend Share | 332.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 52.1844 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
07/11 10:50 EST - zacks.com
Smart Money Going in Senior Health: Key Stocks in Elderly Care
RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.
Smart Money Going in Senior Health: Key Stocks in Elderly Care
RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.
07/11 05:07 EST - globenewswire.com
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
Discover comprehensive insights with the "North America Cystoscopes Market Outlook to 2033" report. Analyze market data, company shares, and segment details for Flexible and Rigid Cystoscopes. Develop strategic plans and investment strategies by identifying growth opportunities in the North America...
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
Discover comprehensive insights with the "North America Cystoscopes Market Outlook to 2033" report. Analyze market data, company shares, and segment details for Flexible and Rigid Cystoscopes. Develop strategic plans and investment strategies by identifying growth opportunities in the North America...
07/07 12:41 EST - zacks.com
HLN vs. SYK: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
HLN vs. SYK: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
07/01 08:00 EST - globenewswire.com
Stryker to announce financial results for its second quarter of fiscal year 2025
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases...
Stryker to announce financial results for its second quarter of fiscal year 2025
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases...
06/30 09:31 EST - zacks.com
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
06/26 13:01 EST - youtube.com
The Big 3: NXT, ANET, SYK
Today's trading action added confidence to Dan Deming's perception on the markets, noting widening market breadth as a healthy sign for price action. On individual stocks, he sees growth opportunities in Nextracker (NXT) amid volatility, Arista Networks (ANET) gaining momentum as the stock remains...
The Big 3: NXT, ANET, SYK
Today's trading action added confidence to Dan Deming's perception on the markets, noting widening market breadth as a healthy sign for price action. On individual stocks, he sees growth opportunities in Nextracker (NXT) amid volatility, Arista Networks (ANET) gaining momentum as the stock remains...
06/25 08:15 EST - businesswire.com
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.
06/11 05:00 EST - fool.com
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
06/03 11:09 EST - youtube.com
The 3 Most Overvalued Stocks Top Managers Are Selling in 2025
The best fund managers are scaling back in these expensive stocks this year. 00:00 Introduction 00:39 Netflix NFLX 01:23 Mastercard MA 02:07 Stryker SYK Susan Dziubinski: I'm Susan Dziubinski with Morningstar.
The 3 Most Overvalued Stocks Top Managers Are Selling in 2025
The best fund managers are scaling back in these expensive stocks this year. 00:00 Introduction 00:39 Netflix NFLX 01:23 Mastercard MA 02:07 Stryker SYK Susan Dziubinski: I'm Susan Dziubinski with Morningstar.
05/30 12:46 EST - zacks.com
PBH vs. SYK: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
PBH vs. SYK: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
05/20 10:26 EST - zacks.com
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.
05/19 13:01 EST - prnewswire.com
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.
05/15 08:05 EST - seekingalpha.com
Baron Opportunity Fund Q1 2025 Top Contributors And Detractors
xAI Holdings led performance, driven by rapid AI innovation, Grok 3 launch, and the strategic acquisition of X, enhancing data access and integration. Spotify delivered strong results with margin expansion, robust user growth despite price hikes, and record free cash flow, positioning it as a...
Baron Opportunity Fund Q1 2025 Top Contributors And Detractors
xAI Holdings led performance, driven by rapid AI innovation, Grok 3 launch, and the strategic acquisition of X, enhancing data access and integration. Spotify delivered strong results with margin expansion, robust user growth despite price hikes, and record free cash flow, positioning it as a...
05/13 20:23 EST - seekingalpha.com
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
Stryker Corporation (NYSE:SYK ) Bank of America Securities 2025 Global Healthcare Conference May 13, 2025 4:40 PM ET Company Participants Preston Wells - Chief Financial Officer Jason Beach - Vice President, Finance and Investor Relations Conference Call Participants Travis Steed - Bank of America...
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
Stryker Corporation (NYSE:SYK ) Bank of America Securities 2025 Global Healthcare Conference May 13, 2025 4:40 PM ET Company Participants Preston Wells - Chief Financial Officer Jason Beach - Vice President, Finance and Investor Relations Conference Call Participants Travis Steed - Bank of America...
05/10 04:10 EST - fool.com
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks
If you read Fundsmith's Owner's Manual, the influence of Warren Buffett on Terry Smith's hedge fund is plainly obvious. Smith references the Oracle of Omaha's wisdom and Berkshire Hathaway's success no fewer than six times in the 17-page document.
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks
If you read Fundsmith's Owner's Manual, the influence of Warren Buffett on Terry Smith's hedge fund is plainly obvious. Smith references the Oracle of Omaha's wisdom and Berkshire Hathaway's success no fewer than six times in the 17-page document.
05/09 17:42 EST - seekingalpha.com
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)
I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to launch soon, potentially boosting its orthopedics and spine businesses. Stryker posted robust Q1...
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)
I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to launch soon, potentially boosting its orthopedics and spine businesses. Stryker posted robust Q1...
05/08 08:00 EST - globenewswire.com
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the...
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the...
05/05 14:20 EST - youtube.com
Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
The Investment Committee kick off the week with their top picks. Don't miss it!
Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
The Investment Committee kick off the week with their top picks. Don't miss it!
05/02 19:30 EST - zacks.com
Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
05/02 14:25 EST - zacks.com
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.